Insiders Bellerophon Therapeutics, Inc. Börse Stuttgart

Equities

6L7A

US0787713009

Market Closed - Börse Stuttgart Other stock markets 11:31:13 13/10/2023 am IST			5-day change	1st Jan Change
0.421 ^EUR	+20.98%		+26.05%	-45.08%

02/05	North American Morning Briefing : Stock Futures -2-	DJ
25/04	North American Morning Briefing : More Tech -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bellerophon Therapeutics, Inc. Announces Resignation of Mary Ann Cloyd and Scott Bruder as Members of Board of Directors	05/03	CI
Bellerophon Therapeutics, Inc. Announces Executive Changes	22/11	CI
Bellerophon Therapeutics, Inc. Announces Executive Changes	22/11	CI
Bellerophon Therapeutics Insider Sold Shares Worth $111,776, According to a Recent SEC Filing	17/23/17	MT
Bellerophon Therapeutics, Inc. Announces Resignation of Theodore Wang as a Member of the Company's Board	13/23/13	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Crispin Teufel as Board of Director	15/23/15	CI
Bellerophon Therapeutics Announces Separation of Peter Fernandes as Chief Executive Officer, Effective July 15, 2023	30/23/30	CI
Bellerophon Therapeutics, Inc. Appoints Peter Fernandes, as Principal Financial and Accounting Officer	12/23/12	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Nicholas Laccona as Principal Financial and Accounting Officer	26/23/26	CI
Bellerophon Therapeutics, Inc. Announces New Board Appointment	08/22/08	CI
Avantor Names Jonathan Peacock Chairman	13/22/13	MT
Bellerophon Therapeutics, Inc. Appoints Peter Fernandes as Interim Principal Executive Officer	12/21/12	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Fabian Tenenbaum as A Director	13/21/13	CI
Bellerophon Therapeutics, Inc. Announces Resignation of Chief Executive Officer	13/21/13	CI
Bellerophon Therapeutics, Inc. Appoints Nicholas Laccona as Principal Financial Officer and Principal Accounting Officer	06/21/06	CI
Bellerophon Therapeutics : Chief Financial Officer Assaf Korner to Resign Next Month	01/21/01	MT
Assaf Korner Intent to Resign as Chief Financial Officer of Bellerophon Therapeutics, Inc, Effective September 10, 2021	01/21/01	CI
Bellerophon Therapeutics, Inc. Announces Executive Changes	26/21/26	CI
Jonathan Peacock Intends Not Stand for Re-Election to the Board of Bellerophon Therapeutics, Inc	01/21/01	CI
Insider Trends: Selling By Insiders Lingers at Bellerophon Therapeutics	23/21/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bellerophon Therapeutics, Inc. Börse Stuttgart

Equities

6L7A

US0787713009

Insiders

Filters